the market?
Protalix BioTherapeutics, Inc.
NYSEMKT: PLX
5.21
0.00
(0.00%)
| Today's Open | $5.25 |
|---|---|
| Previous Close | $5.21 |
| Daily Range | $5.20 - $5.29 |
| 52-Week Range | $4.71 - $6.80 |
| Market Cap | $487.2M |
| P/E Ratio | -47.36 |
| Dividend (Yield) | $0.00 (0.0%) |
| Volume | 95,459 |
| Average Daily Volume | 160,626 |
| Current FY EPS | -$0.17 |
How do you think PLX
will perform against the market?
Top PLX Bull/Bear Pitches
yellowear (< 20)
Submitted
December 20, 2008
Based on the news on the street and the performance of the stock at these levels, this company has the potential of reaching 2000% in the next 4 years. This stock has found a bottom like AKS did seve … More
cashsage (< 20)
Submitted
April 22, 2009
PLX has a too high valuation compared to its sales potential. Its current sales are nil, and so is one of the most loss making companies.
News & Commentary
BioMarin Earnings: An Early Look
Let's look forward to this company's next earnings report.Who's Going to Buy This Orphan Drugmaker?
Protalix is exploring its options.Why Protalix BioTherapeutics Shares Soared
Is this meaningful or just another movement?CAPScall of the Week: Amicus Therapeutics
A weekly adventure in giving unknown companies some attention.Why Synageva Is Poised to Underperform
Market-lagging returns could be written in this 1-Star.Sector
Healthcare
Industry
Drugs
Protalix BioTherapeutics, Inc. (PLX) Description
A clinical stage biopharmaceutical company that is focused on developing and manufacturing recombinant therapeutic proteins that are produced through its proprietary plant cell system. Website: http://www.protalix.com/
